Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-04-21
1999-10-12
Chan, Christina Y.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303871, 53038815, 53038822, C12D 2108
Patent
active
059657090
ABSTRACT:
IgE antagonists comprising one or more of the Fc.sub..epsilon. RI receptor-binding determinant sites of human IgE are described. The disclosed antagonists include IgE variants, peptide antagonists, peptidomimetics and other small molecules. The antagonists are useful in raising and screening anti-IgE antibodies, in the isolation and purification of Fc.sub..epsilon. RI receptor, and in the treatment of allergic disease.
REFERENCES:
patent: 4161522 (1979-07-01), Hamburger
patent: 4714759 (1987-12-01), Whitaker, Jr.
patent: 4861579 (1989-08-01), Meyer, Jr. et al.
patent: 4940782 (1990-07-01), Rup et al.
Baniyash and Eshhar, "Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE"; Eur. J. Immunol., 14: 799-807 (1984).
Baniyash et al., "Anti-I GE monoclonal antibodies directed at the Fc.sub..epsilon. receptor binding site", Molecular Immunology, 25(8): 705-711 (1988).
Burt and Stanworth, "Inhibition of binding rat to IgE to rat mast cells by synthetic IgE peptides"Eur. J. Immunol, 17: 437-440 (1987).
Conrad, D. H., "Fc.sub..epsilon. RII/CD23: The low affinity receptor for IgE", Ann. Rev. Immunol., 8: 623-645 (1990).
Conrad et al., "The interaction of human and rodent IgE with the human basophil IgE receptor", J. of Immunol., 130(1): 327-333 (1983).
Burt et al., "Analysis of the interaction between rat immunoglobulin E and rat mast cells using anti-peptide antibodies", Mol. Immunol., 24(4): 379-389 (1987).
Disenhofer, "Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-.ANG. resolution", Biochemistry, 20(9): 2361-2370 (1981).
Riske, F. et al.,"High affinity human IgE receptor(FcERI)", J. Biol. Chem., 266(17): 11245-11251 (1991).
Liu, F.T. et al., "Expression of a biologically active fragment of human IgE epsilon chain in Escherichia coli,", Proc. Natl. Acad. Sci., 81: 5369-5373 (1984).
Kurokawa, T. et al., "Expression of human immunoglobulin espilon chain cDNA in E coli", Nucleic Acid Res., 11(10):3077-3085 (1983).
Geha, R.S. et al., "IgE sites relevant for binding to type 1 Fc epsilon (FCER) receptors on mast cells", J. of Allergy & Clin. Immunol., 79(1): abstract, p. 129, No. 20 (1987).
Hakimi et al., "The .alpha. subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding", J. Biol. Chem., 265(3): 22079-22081 (1990).
Helm et al., "The mast cell binding site on human immunoglobulin E," Nature, 331: 180-183 (1988).
Helm et al., "Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human .epsilon.-chain fragment of 76 amino acids", Proc. Natl. Acad. Sci., 86:9465-9469 (1989).
Kulczycki, Jr. et al., "The interaction of IgE with rat basophilic leukemia cells I. Evidence for specific binding of IgE", J. Exp. Med., 139: 600-616 (1974).
Nio et al., "Inhibition of histamine release by synthetic human IgE peptide fragments: structure-activity studies", Peptide Chemistry, 203-208 (1989).
Nissim et al., "Mapping of the high affinity Fc.sub..epsilon. receptor binding site to the third constant region domain of IgE", EMBO, 101-107 (1991).
Nitta et al., "Preliminary trial of specific targeting against malignant glioma", Lancet, 368-371 (1990).
Padlan & Davies, "A model of the Fc of immunoglobulin E", Mol. Immunol., 23(10): 1063-1075 (1986).
Robertson & Liu, "IgE structure-function relationships defined by sequence directed antibodies induced by synthetic peptides", Mol. Immunol., 25(2): 103-113 (1988).
Schwarzbaum et al., "Mapping of murine IgE epitopes involved in IgE-Fc.sub..epsilon. receptor interactions", Eur. J. Immunol., 19:1015-1023 (1989).
Stanworth et al.,"Synthetic peptides comprising sequences of the human immunoglobulin E heavy chain capable of releasing histamine", Biochem. J., 180: 665-668 (1979).
Stanworth et al., "The use of synthetic peptides in the delineation of immunoglobulin antigenic epitopes and Fc effector functions", CIBA Found, Symp., 119: 226-244 (1986).
Vercelli et al., "The B-cell binding site on human immunoglobulin E", Nature, 338: 649-651 (1989).
Weetall et al., "Mapping the site of interaction between murine IgE and its high affinity receptor with chimeric Ig", J. of Immunol., 145(11): 3849-3854 (1990).
Ishizaka, K., "Immunoglobulin E (IgE)", Methods in Enzymology, 116(Part II):76-94 (1985).
Hoffman, D. R., "Enzyme-linked immunosorbent assays (ELISA) for immunoglobulin E and blocking and antibodies", Methods in Enzymology, chapter 45, 73: 656-666 (1981).
Neurath, A. R., "Use of .sup.125 I-labeled anti-2,4-dinitrophenyl (DNP) antibodies as a general tracer in solid-phase radioimmunoassays", Methods in Enzymology, 73:127-138 (1981).
Tung, A. S., "Production, purification, and characterization of antigen-specific murine monoclonal antibodies of IgE class", Methods in Enzymology, chapter 6, 92:47-66 (1983).
Metzger & Kinet, "How antibodies work: focus on Fc receptors", FASEB J., 2(1): 3-11 (1988).
Hook et al., "Monoclonal Antibodies Defining Epitopes on IgE", BASOPHILS, MAST CELLS, and IgE II, abst 6008 (1987).
Lazar et al., Transforming Growth Factor .alpha.: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities, Molecular and Cellular Biology 8(3): 1247-1252 (1988).
Tao et al., Role of Carbohydrate in the Structure and Effector Functions Mediated by the Human IgG Constant Region, J. Immunol. 143(8): 2595-2601 (1989).
Burgess et al., "Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue", J. Cell Biol. 111: 2129-2138 (1990).
Glennie et al. "Preparation and Performance of Bispecific F(ab'.gamma.).sub.2 Antibody Containing Thioether-Linked Fab'.gamma. Fragments", J. Immunol. 139(7): 2367-2375 (1987).
Hook et al., "Monoclonal Antibodies Defining Epitopes on Human IgE" Mol. Immunol. 28(6): 631-639 (1991).
Kabat, Sequence of Proteins Immunological Intent, 4th Edition, Table of Contents, pp. 41-42, 167-168 (1987).
Queen et al., "A humanized antibody that binds to the interleukin 2 receptor", PNAS USA 88: 10029-10033 (1989).
Nissim et al., "Fine specificity of the IgE Interaction with the Low and High Affinity Fc Receptor", J. Immunol., 150: 1365-1374 (1993).
A. R. Duncan et al., "Localization of the binding site for the human high-affinity Fc receptor on IgG", Nature 332: 563-564 (1988).
R. Jefferis et al., "Molecular Definition of Interaction Sites on Human IgG for Fc Receptors (huFc.gamma.R)", Mol. Immunol. 27: 1237-1240 (1990).
Kabat, Sequence of Proteins of Immunological Intent, 5th Edition, vol. 1, pp. 662-663, 671-672, 680-681, 689-690, 697, 701-702, 710, 719-720, 2275-2276 (1991).
Riechmann et al., Nature, 332, 24. Mar. 1988. pp. 323-327.
Kumar et al., P.N.A.S. USA, vol. 87:1337-1341, Feb. 1990.
Rudikoff et al., P.N.A.S. USA, vol. 79: 1979-1983, Mar. 1982.
Schwarzbaum et al., Eur. J. Immunol. vol. 19, 1015-1023, Jun. 1989.
Nissim et al., Methods., vol. 8, 124-132, Mar. 1995.
Jardieu Paula M.
Presta Leonard G.
Chan Christina Y.
Genentech Inc.
Nolan Patrick J.
Svoboda Craig G.
LandOfFree
IgE antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IgE antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IgE antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-653891